Novare Pharmaceuticals develops therapeutic products that have the potential to reduce inflammation from disease or traumatic injury, minimize breast cancer tumor growth and metastasis, prevent collateral fibrosis from radiation therapy, and help the body regenerate fat tissue. By regulating RHAMM with its proprietary peptides, Novare is at the forefront of solving some of the world’s biggest medical challenges.

We invite researchers, advocates and investors alike to join us in the exploration and further elucidation of this exciting medical technology.

This email address is being protected from spambots. You need JavaScript enabled to view it.

100 High St., 28th Floor
Boston, MA 02110
617.419.1800
This email address is being protected from spambots. You need JavaScript enabled to view it.